<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The human immune system has evolved multiple cellular and humoral defense mechanisms against the lymphotropic virus, EBV </plain></SENT>
<SENT sid="1" pm="."><plain>NK cells, suppressor T-cells, cytotoxic K-cells, memory T-cells, and humoral immune responses usually subdue the virus into latency </plain></SENT>
<SENT sid="2" pm="."><plain>Individuals with <z:hpo ids='HP_0002721'>immune deficiency</z:hpo> are at great risk of developing immunoregulatory disturbances and <z:e sem="disease" ids="C0024314" disease_type="Neoplastic Process" abbrv="">lymphoproliferative diseases</z:e> when confronted by EBV </plain></SENT>
<SENT sid="3" pm="."><plain>The <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> of B-cells by EBV provokes a marked activation of immunoregulatory T-cells and requires restoration of immune homeostasis during convalescence </plain></SENT>
<SENT sid="4" pm="."><plain>This is accomplished with difficulty in an individual with significant immune defects </plain></SENT>
<SENT sid="5" pm="."><plain>The <z:hpo ids='HP_0001417'>X-linked</z:hpo> lymphoproliferative syndrome is an exemplary model for studying EBV in immune deficient individuals </plain></SENT>
<SENT sid="6" pm="."><plain>Boys with XLP can develop acquired <z:hpo ids='HP_0004432'>agammaglobulinemia</z:hpo>, <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, <z:hpo ids='HP_0011010'>chronic</z:hpo> or fatal IM, and a variety of B-cell malignant <z:hpo ids='HP_0002665'>lymphomas</z:hpo> following <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> by the virus </plain></SENT>
<SENT sid="7" pm="."><plain>We have identified multiple immune defects in the patients and progressive immunoregulatory disturbances following <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> by the virus </plain></SENT>
<SENT sid="8" pm="."><plain>Other patients with <z:hpo ids='HP_0002721'>immune deficiency</z:hpo> syndromes, i.e., <z:hpo ids='HP_0001251'>ataxia</z:hpo> <z:hpo ids='HP_0001009'>telangiectasia</z:hpo> or the renal transplant recipient, are also at increased risk for developing EBV-induced <z:e sem="disease" ids="C0024314" disease_type="Neoplastic Process" abbrv="">lymphoproliferative diseases</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Moreover, certain families are at increased risk for EBV-associated <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e>, especially those with a triad of manifestations (i.e., <z:hpo ids='HP_0002960'>autoimmunity</z:hpo>, <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo>, and <z:hpo ids='HP_0002665'>lymphoma</z:hpo>) </plain></SENT>
<SENT sid="10" pm="."><plain>Chromosomal breakage as seen in patients with <z:hpo ids='HP_0001251'>ataxia</z:hpo> <z:hpo ids='HP_0001009'>telangiectasia</z:hpo> may predispose to <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">leukemogenesis</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>Immunoregulatory defects are also probably predisposing factors to <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">lymphomagenesis</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>Both inherited and acquired defects can render persons vulnerable to <z:hpo ids='HP_0001909'>leukemia</z:hpo> and <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
</text></document>